|
Volumn 18, Issue 1, 2004, Pages 69-72
|
Clinical trial of sequential antiviral therapy for patients with chronic hepatitis B in China
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ANTIVIRUS AGENT;
DRUG DERIVATIVE;
IMMUNOLOGICAL ADJUVANT;
LAMIVUDINE;
THYMOSIN;
THYMOSIN ALPHA1;
ARTICLE;
CHINA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
HEPATITIS B;
HUMAN;
TREATMENT OUTCOME;
ADJUVANTS, IMMUNOLOGIC;
ANTIVIRAL AGENTS;
CHINA;
DRUG THERAPY, COMBINATION;
HEPATITIS B, CHRONIC;
HUMANS;
INTERFERON-ALPHA;
LAMIVUDINE;
THYMOSIN;
TREATMENT OUTCOME;
|
EID: 33745892406
PISSN: 10039279
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|